CD79A and cholangiocarcinoma: Indeed, antibodies raised against liver fluke granulin block its ability to drive proliferation of CCA cell lines (14) and, hence, bootstrap support for a vaccination strategy targeting Ov-GRN-1 in the gastro-intestinal tract, for example through induction of mucosal IgA and IgG responses [23,62].